Viewing Study NCT06786520

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-03-02 @ 6:24 PM
Study NCT ID: NCT06786520
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-19
First Post: 2025-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults
Sponsor: ViiV Healthcare
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cabotegravir (CAB) View
None Ultra Long Acting (ULA) View
None Long Acting (LA) View
None Pharmacokinetics View
None Safety View
None Tolerability View
None Healthy Adult View